» Articles » PMID: 35064045

Neural Ventilatory Drive Decline As a Predominant Mechanism of Obstructive Sleep Apnoea Events

Overview
Journal Thorax
Date 2022 Jan 22
PMID 35064045
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In the classic model of obstructive sleep apnoea (OSA), respiratory events occur with sleep-related dilator muscle hypotonia, precipitating increased neural ventilatory 'drive'. By contrast, a drive-dependent model has been proposed, whereby drive promotes dilator muscle hypotonia to precipitate respiratory events. Here we determine the extent to which the classic versus drive-dependent models of OSA are best supported by direct physiological measurements.

Methods: In 50 OSA patients (5-91 events/hour), we recorded ventilation ('flow', oronasal mask and pneumotach) and ventilatory drive (calibrated intraoesophageal diaphragm electromyography, EMG) overnight. Flow and drive during events were ensemble averaged; patients were classified as if flow fell/rose simultaneously with drive. Overnight effects of lower drive on flow, genioglossus muscle activity (EMGgg) and event risk were quantified (mixed models).

Results: On average, ventilatory drive fell (rather than rose) during events (-20 (-42 to 3)%, median (IQR)) and was strongly correlated with flow (R=0.78 (0.24 to 0.94)). Most patients (30/50, 60%) were classified as exhibiting event pathophysiology. Lower drive during sleep was associated with lower flow (-17 (-20 to -14)%/drive) and EMGgg (-3.5 (-3.8 to -3.3)%/drive) and greater event risk (OR: 2.2 (1.8 to 2.5) per drive reduction of 100%); associations were concentrated in patients with drive-dependent OSA (ie, flow: -37 (-40 to -34)%/drive, OR: 6.8 (5.3 to 8.7)). Oesophageal pressure-without tidal volume correction-falsely suggested rising drive during events ( model).

Conclusions: In contrast to the prevailing view, patients with OSA predominantly exhibit event pathophysiology, whereby flow is lowest at nadir drive, and lower drive raises event risk. Preventing ventilatory drive decline is therefore considered a target for OSA intervention.

Citing Articles

Phenotyping Using Polysomnography Attributes Reduced Respiratory Events after Continuous Positive Airway Pressure Therapy to Improved Upper Airway Collapsibility.

Tolbert T, Parekh A, Rapoport D, Ayappa I Ann Am Thorac Soc. 2024; 22(3):438-449.

PMID: 39499779 PMC: 11892672. DOI: 10.1513/AnnalsATS.202402-171OC.


Altered control of breathing in a rat model of allergic lower airway inflammation.

Morgan B, Song R, McDermott I, Brinkman J, Holbert K, Oler A J Neurophysiol. 2024; 132(5):1650-1666.

PMID: 39382982 PMC: 11573259. DOI: 10.1152/jn.00301.2023.


Morphological Prediction of CPAP Associated Acute Respiratory Instability.

Nassi T, Oppersma E, Labarca G, Donker D, Westover M, Thomas R Ann Am Thorac Soc. 2024; .

PMID: 39288402 PMC: 11708763. DOI: 10.1513/AnnalsATS.202311-979OC.


Sex-specific age-related worsening of pathological endotypic traits in patients with obstructive sleep apnea.

Hang L, Tsai Y, Finnsson E, Agustsson J, Sands S, Cheng W Sleep. 2024; 48(1.

PMID: 39127876 PMC: 11725508. DOI: 10.1093/sleep/zsae185.


Gefapixant as a P2X3 receptor antagonist treatment for obstructive sleep apnea: a randomized controlled trial.

Robbins J, Sands S, Maganti L, Crumley T, Fox-Bosetti S, Hussain A J Clin Sleep Med. 2024; 20(12):1905-1913.

PMID: 39069967 PMC: 11609840. DOI: 10.5664/jcsm.11272.


References
1.
Vena D, Azarbarzin A, Marques M, Op de Beeck S, Vanderveken O, Edwards B . Predicting sleep apnea responses to oral appliance therapy using polysomnographic airflow. Sleep. 2020; 43(7). PMC: 7355408. DOI: 10.1093/sleep/zsaa004. View

2.
Jordan A, White D, Lo Y, Wellman A, Eckert D, Yim-Yeh S . Airway dilator muscle activity and lung volume during stable breathing in obstructive sleep apnea. Sleep. 2009; 32(3):361-8. PMC: 2647790. DOI: 10.1093/sleep/32.3.361. View

3.
McGinley B, Schwartz A, Schneider H, Kirkness J, Smith P, Patil S . Upper airway neuromuscular compensation during sleep is defective in obstructive sleep apnea. J Appl Physiol (1985). 2008; 105(1):197-205. PMC: 2494825. DOI: 10.1152/japplphysiol.01214.2007. View

4.
Edwards B, Sands S, Owens R, Eckert D, Landry S, White D . The Combination of Supplemental Oxygen and a Hypnotic Markedly Improves Obstructive Sleep Apnea in Patients with a Mild to Moderate Upper Airway Collapsibility. Sleep. 2016; 39(11):1973-1983. PMC: 5070751. DOI: 10.5665/sleep.6226. View

5.
Younes M, Riddle W, Polacheck J . A model for the relation between respiratory neural and mechanical outputs. III. Validation. J Appl Physiol Respir Environ Exerc Physiol. 1981; 51(4):990-1001. DOI: 10.1152/jappl.1981.51.4.990. View